ABBOTT LABORATORIES A/S: Financial statements 2021
CVR: 31528615
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 259,193,466 and a net result of DKK 5,974,314 compared with DKK 4,824,760 the year before. That is an increase of 32.3% compared with the year before. The profit margin was 2.3%. Equity in the 2021 report amounted to DKK 117,689,140. The solvency ratio was 64.2%. The company had 39 employees in the financial year.
- Revenue
- DKK 259,193,466
- Gross Profit
- DKK 44,159,403
- Profit/Loss
- DKK 5,974,314
- Equity
- DKK 117,689,140
- Total Assets
- DKK 183,201,805
- Employees
- 39
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 259.2 mio. | 44.2 mio. | 6 mio. | 117.7 mio. | 39 |
| 2020 | 195.9 mio. | 39.7 mio. | 4.8 mio. | 111.7 mio. | 36 |
| 2019 | 162.9 mio. | 39.8 mio. | 6 mio. | 106.9 mio. | 36 |
| 2018 | 129 mio. | 22.5 mio. | -2.1 mio. | 150.8 mio. | 29 |
| 2017 | 147.4 mio. | 34.4 mio. | 5.7 mio. | 58.9 mio. | 31 |
Official annual report
Find more companies like ABBOTT LABORATORIES A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
ABBOTT LABORATORIES A/S has published its annual report for 2020. Revenue came to DKK 195,943,716, and the net result was DKK 4,824,760.
About ABBOTT LABORATORIES A/S
ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.